Erschienen in:
01.12.2004 | Adis Drug Profile
Pregabalin in Painful Diabetic Peripheral Neuropathy
A Viewpoint by M.S. Chong
verfasst von:
M. S. Chong
Erschienen in:
Drugs
|
Ausgabe 24/2004
Einloggen, um Zugang zu erhalten
Excerpt
Pregabalin is a gabapentin derivative with superior antiallodynic and anticonvulsant activity for the equivalent dose. Three large, double-blind studies in a total of 729 randomised patients with painful diabetic peripheral neuropathy (DPN) provide convincing evidence that pregabalin 300 or 600 mg/day dosed three times daily is superior to placebo for alleviating this condition. Based on these studies, the estimated number needed to treat (NNT) for a 50% reduction in baseline pain score assessed on a visual analogue scale is between 3.2 and 4.2. …